The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN. VER 2025, 8 (5s), 154-161. https://doi.org/10.64149/J.Ver.8.5s.154-161.